VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
Illustration for: Zhongji Innolight Slides on Its $6.8B Hong Kong Debut
Value Add VC/Pulse/IPO$6.8B raised

Zhongji Innolight Slides on Its $6.8B Hong Kong Debut

Zhongji Innolight, the world's top optical-interconnect supplier, raised $6.8 billion in Hong Kong's biggest listing in seven years, but shares fell as much as 5% on debut as the global AI-stock selloff overshadowed the offering.

TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 30, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Zhongji Innolight priced its Hong Kong IPO at HK$980 per share, below the HK$1,010 maximum, raising roughly $6.8 billion in Asia's second-largest listing this year behind CXMT's $8.6 billion Shanghai debut

2

The company has ranked first globally in optical interconnect solutions revenue for five straight years, with 2025 revenue of 38.24 billion yuan (~$5.6 billion), up 60% year-over-year, and net profit up 109%

3

More than 30 cornerstone investors, including BlackRock, Temasek, and the Canada Pension Plan Investment Board, committed to the offering before the debut-day slide

4

Shares fell as much as 3-5% on debut as the stock absorbed the broader global downturn in AI-sector sentiment that has hit chip and AI-infrastructure names across US and Asian markets this week

TC

The VC Read · Trace's Take

Trace Cohen

A company growing revenue 60% and profit 109% still opening down on debut is exactly the kind of mismatch that shows how much the current chip-sector selloff is about sentiment, not fundamentals. BlackRock and Temasek didn't misjudge the business -- they got caught by macro timing. Worth watching as a re-entry point once the broader AI-infra repricing settles, not a reason to doubt the underlying optical-interconnect thesis.

Tech IPO Tracker →

Analysis

Zhongji Innolight, the Chinese optical-interconnect supplier that ranks first globally in the category for five consecutive years, priced its Hong Kong IPO at HK$980 per share -- below the HK$1,010 maximum indicated price -- raising roughly $6.8 billion in what became Hong Kong's biggest share sale in seven years and Asia's second-largest listing this year, trailing only memory-chip maker CXMT's $8.6 billion Shanghai debut.

The company's fundamentals going into the listing were strong by any measure: 2025 revenue of 38.24 billion yuan (about $5.6 billion), up 60% year-over-year, with net profit attributable to shareholders surging 109% to 10.8 billion yuan. Zhongji supplies optical transceivers that convert electrical and optical signals to support the high-speed data transmission AI data centers depend on, putting it squarely in the same infrastructure category as GlobalFoundries' newly-funded silicon photonics push in the US. More than 30 cornerstone investors, including BlackRock, Temasek Holdings, and the Canada Pension Plan Investment Board, had committed to the offering ahead of the debut.

“More than 30 cornerstone investors, including BlackRock, Temasek Holdings, and the Canada Pension Plan Investment Board, had committed to the offering ahead of the debut.”

Despite that demand and those fundamentals, shares fell as much as 3-5% on their Hong Kong Stock Exchange debut Thursday. The weakness wasn't specific to Zhongji -- it reflects the broader global downturn in AI-sector sentiment that has already wiped more than $1.5 trillion off chip stocks in the US and spread into Japanese and Korean names this same week. Even a company with genuinely excellent underlying numbers couldn't escape the sector-wide repricing happening simultaneously across markets.

For investors tracking the global AI infrastructure supply chain, Zhongji's debut is a reminder that optical interconnects sit at the center of both the US and China's AI buildout strategies -- and that strong fundamentals are currently necessary but not sufficient to guarantee a strong public-market reception. What to watch: whether Zhongji's shares stabilize once the broader chip selloff cools, and how its Hong Kong listing performs relative to its existing Shenzhen-listed shares over the coming weeks.

ShareXLinkedInEmail

Analysis and editorial commentary by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Jul 30, 2026

Apnimed Prices $150M IPO for First Sleep Apnea Pill

Illustration for: Apnimed Prices $150M IPO for First Sleep Apnea Pill
IPO$150M IPO

Apnimed Prices $150M IPO for First Sleep Apnea Pill

Apnimed, developer of what could become the first FDA-approved pill for obstructive sleep apnea, is pricing a $150 million Nasdaq IPO tonight, part of a 55% average return year for US biotech listings.

IPO· Jul 29, 2026

Goldman-Backed Attovia Seeks $212.5M in Biotech IPO

Illustration for: Goldman-Backed Attovia Seeks $212.5M in Biotech IPO
IPO$212.5M IPO

Goldman-Backed Attovia Seeks $212.5M in Biotech IPO

Attovia Therapeutics is seeking up to $212.5 million in a US IPO, offering 12.5 million shares at $15-$17 each, backed by Goldman Sachs Alternatives, Deep Track Capital, Frazier Life Sciences, and venBio.

IPO· Jul 28, 2026

GrubMarket Files Confidential IPO at $4.5B Valuation

Illustration for: GrubMarket Files Confidential IPO at $4.5B Valuation
IPO$4.5B valuation

GrubMarket Files Confidential IPO at $4.5B Valuation

AI-powered food supply chain company GrubMarket confidentially filed for a US IPO, months after reaching a $4.5 billion valuation in a $50 million February Series H round.

@Trace_Cohen·t@nyvp.com